Name | Type | Posted | Actions |
|---|---|---|---|
Amendment 037 - DRIVe EZ BAA.pdf | Apr 22, 2025 | ||
Amendment 036 - DRIVe EZ BAA.pdf | Feb 14, 2025 | ||
Amendment 035 - DRIVe EZ BAA.pdf | Jan 13, 2025 | ||
Amendment 034 - DRIVe EZ BAA.pdf | Nov 26, 2024 | ||
Amendment 033 - DRIVe EZ BAA.pdf | Oct 31, 2024 | ||
Amendment 032 - DRIVe EZ BAA.pdf | Oct 11, 2024 | ||
Amendment 031 - DRIVe EZ BAA.pdf | Sep 30, 2024 | ||
Amendment 030 - DRIVe EZ BAA.pdf | Sep 24, 2024 | ||
Amendment 029 - DRIVe EZ BAA.pdf | May 9, 2024 | ||
Amendment 028 - DRIVe EZ BAA.pdf | May 2, 2024 | ||
Amendment 027 - DRIVe EZ BAA.pdf | Apr 24, 2024 | ||
Amendment 026 - DRIVe EZ BAA.pdf | Mar 12, 2024 | ||
Amendment 025 - DRIVe EZ BAA.pdf | Mar 4, 2024 | ||
Amendment 024 - DRIVe EZ BAA.pdf | Feb 26, 2024 | ||
Amendment 023 - DRIVe EZ BAA.pdf | Feb 12, 2024 | ||
Amendment 022 - DRIVe EZ BAA.pdf | Feb 5, 2024 | ||
Amendment 021 - DRIVe EZ BAA.pdf | Jan 19, 2024 | ||
Amendment 020 - DRIVe EZ BAA.pdf | Jan 11, 2024 | ||
Amendment 019 - DRIVe EZ BAA.pdf | Jan 8, 2024 | ||
Amendment 018 - DRIVe EZ BAA.pdf | Dec 14, 2023 | ||
Amendment 017 - DRIVe EZ BAA.pdf | Nov 15, 2023 | ||
Amendment 016 - DRIVe EZ BAA.pdf | Oct 30, 2023 | ||
Amendment 015 - DRIVe EZ BAA.pdf | Oct 30, 2023 | ||
Amendment 014 - DRIVe EZ BAA.pdf | Sep 26, 2023 | ||
Amendment 013 - DRIVe EZ BAA.pdf | Sep 14, 2023 | ||
Amendment 012 - DRIVe EZ BAA.pdf | Sep 14, 2023 | ||
Amendment 011 - DRIVe EZ BAA.pdf | Jun 29, 2023 | ||
Amendment 010 - DRIVe EZ BAA.pdf | May 25, 2023 | ||
Amendment 009 - DRIVe EZ BAA.pdf | May 18, 2023 | ||
Amendment 008 - DRIVe EZ BAA.pdf | May 1, 2023 | ||
Amendment 007 - DRIVe EZ BAA.pdf | Feb 3, 2023 | ||
Amendment 006 - DRIVe EZ BAA.pdf | Feb 1, 2023 | ||
Amendment 005 - DRIVe EZ BAA.pdf | Jan 11, 2023 | ||
Amendment 004 - DRIVe EZ BAA.pdf | Dec 15, 2022 | ||
Amendment 003 - DRIVe EZ BAA.pdf | Nov 14, 2022 | ||
Amendment 002 - DRIVe EZ BAA.pdf | Nov 8, 2022 | ||
Amendment 001 - DRIVe EZ BAA_10.18.22.pdf | Oct 18, 2022 | ||
EZ-BAA-22-100-SOL-00003_10.18.22.pdf | Oct 18, 2022 |
BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)
Contact and place of performance
BARDA DCMA DRIVe Team
Not specified
This announcement serves as a reissuance of the BARDA DRIVe EZ-BAA, now known as EZ-BAA-22-100-SOL-00003. This announcement hereby supersedes and replaces prior iterations of the BARDA DRIVe EZ-BAA (e.g. BAA-20-100-SOL-0002). Please reference the attached announcement and applicable amendments for specifics. Additionally, please visit https://drive.hhs.gov/. _______ Amendment 001: This amendment to the EZBAA hereby o...
View moreThe Office of Assistant Secretary for Preparedness and Response, through BARDA - ASPR / DAAPPO / BARDA DCMA, has issued solicitation DRIVeEZBAA22100SOL00003. This notice serves as a reissuance of the BARDA DRIVe Easy Broad Agency Announcement (EZ-BAA) and supersedes all prior iterations. The requirement falls under NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) and PSC AN13 Health R&D Services; Health Care Services; Experimental Development. This broad agency announcement facilitates research and development across various health-related sectors, including biotechnology and experimental health services.
The scope of this announcement encompasses several specific research Areas of Interest (AOI) that are opened, paused, or closed through successive amendments. These include initiatives such as Digital Medical Countermeasures (MCMs), Vaccines on Demand, Influenza Vaccine Innovation, Agnostic Diagnostics, and Lab at Home. As of the most recent update in Amendment 037, specific areas including Healing Lungs, ReBooT, and Type to Treat have been closed. Other segments, such as ReDIRECT and DRIVe Forward, have undergone revisions to their technical topics and closing dates to align with current research priorities.
Submissions for this solicitation are accepted until the final response deadline of October 18, 2027. The BARDA DCMA DRIVe Team serves as the primary point of contact for this effort. Documentation for the opportunity includes 38 attachments, primarily consisting of amendments that detail the specific requirements, technical revisions, and individual schedules for each Area of Interest.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.